Epigenetic gene regulation in the germline
种系中的表观遗传基因调控
基本信息
- 批准号:10581898
- 负责人:
- 金额:$ 22.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-05 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAddressAdministrative SupplementBiologyCRISPR screenComplementComplexDNA DamageDefectDevelopmentDevelopmental ProcessDiseaseEmbryoEnsureEpigenetic ProcessFemaleFoundationsGene ExpressionGene Expression RegulationGenerationsGeneticGenomeGerm CellsGlobal ChangeGrantHumanLifeMaintenanceMeiosisMicroscopeMitosisMolecularNuclearOogenesisOutcome StudyOvarian TissueOvaryPathway interactionsPhasePositioning AttributeProcessProductionPublic HealthReproductionReproductive HealthResearchResearch SupportSex ChromosomesSpermatocytesSpermatogenesisTesticular TissueTestingTestisWorkcohesioneggepigenetic regulationepigenomeepigenomicshigh resolution imagingimaging systeminnovationmalenext generationnoveloocyte maturationparent projectpostnatalprogramsresponsesexual dimorphismsperm cellstem cellstherapy development
项目摘要
ABSTRACT
One of the greatest mysteries in biology concerns how life has perpetuated, and continues to perpetuate, from
generation to generation. A key feature of the mammalian germline is its sexual dimorphism: spermatogenesis
and oogenesis. These dimorphic developmental processes are inherently complex, and this complexity poses
significant challenges to understanding the perpetuity of life and the development of treatments for various
germline-derived genetic and epigenetic diseases. Thus, in this R35 application, our research directions
converge to address the following question: How do epigenetic mechanisms govern distinct sexually
dimorphic processes in spermatogenesis and oogenesis, culminating in the generation of functional
sperm and eggs? Since I became independent ten years ago, I and my team have worked to construct a
detailed picture of the epigenetic mechanisms that govern mammalian spermatogenesis. We have shown that
the mitosis-to-meiosis transition in germ cell development is notable for not only global changes in gene
expression but the dynamic reorganization of the epigenome; in brief, we have revealed that meiosis itself is a
process of global epigenomic reprogramming. My research program has pioneered these concepts and
developed innovative approaches to decode germline mechanisms crucial for preparing the next generation,
providing a rigorous foundation for future research.
To understand key sexually dimorphic processes, we focus on fundamental processes in
spermatogenesis and oogenesis. In spermatogenesis, postnatal germ cells enter a stem cell stage, undergo
meiosis, and sustain long-term production of sperm. We will elucidate the global epigenetic mechanisms
underlying spermatogenesis from the stem cell stage to sperm production, with an emphasis on
dynamic changes in the epigenetic machinery and their importance to the next generation. Since, in males,
meiotic sex chromosome inactivation (MSCI) functions as a key sexually dimorphic process, we will also
determine the molecular functions of DNA damage response pathways—which direct MSCI—in the
epigenetic regulation of the sex chromosomes. In contrast, female germ cells undergo meiosis in embryos
and enter a prolonged stage of meiotic arrest—spanning decades in humans—prior to oocyte maturation. We
will determine epigenetic mechanisms underlying critical stages of oogenesis to complement our study
of male germ cells. Ultimately, we will reveal distinct features and unifying principles of spermatogenesis
and oogenesis. Taking all of this together, we are uniquely positioned to clarify how fundamental germline
mechanisms intersect to ensure genome maintenance, genome defense, and epigenetic gene regulation on a
systemic level. The research directions proposed in this application are cohesive and synergistic, with high
potential to sustain research progress and inform significant, transformative advances in germline biology,
human reproduction, and reproductive health in general.
摘要
生物学中最大的谜团之一是关于生命是如何从
一代又一代。哺乳动物生殖系的一个关键特征是它的性别二型性:精子发生
和卵子发生。这些二态发育过程本质上是复杂的,这种复杂性构成了
理解生命的永恒性和各种疾病的治疗方法的发展面临重大挑战
由种系衍生的遗传病和表观遗传病。因此,在这个R35的应用中,我们的研究方向
共同解决以下问题:表观遗传机制如何控制不同的性别
精子发生和卵子发生中的二态过程,最终产生功能性的
精子和卵子?自从我十年前独立以来,我和我的团队一直在努力构建一个
控制哺乳动物精子发生的表观遗传机制的详细图景。我们已经证明了
生殖细胞发育中从有丝分裂到减数分裂的转变值得注意的不仅仅是基因的全球变化。
而是表观基因组的动态重组;简而言之,我们揭示了减数分裂本身是一种
全球表观基因组重编程的过程。我的研究项目开创了这些概念,
开发了创新的方法来解码对准备下一代至关重要的生殖系机制,
为未来的研究提供了严密的基础。
为了理解关键的性二态过程,我们关注的是
精子发生和卵子发生。在精子发生中,出生后的生殖细胞进入干细胞阶段,经历
减数分裂,并维持精子的长期生产。我们将阐明全球表观遗传机制
从干细胞阶段到精子产生的基本精子发生,重点是
表观遗传机制的动态变化及其对下一代的重要性。因为,在男性身上,
减数分裂性染色体失活(MSCI)作为关键的性二态过程,我们还将
确定引导MSCI的DNA损伤反应通路的分子功能
性染色体的表观遗传调节。相反,雌性生殖细胞在胚胎中经历减数分裂。
在卵母细胞成熟之前,进入减数分裂停滞的长期阶段--在人类中持续数十年。我们
将确定卵子发生关键阶段潜在的表观遗传机制,以补充我们的研究
雄性生殖细胞。最终,我们将揭示精子发生的不同特征和统一原则。
和卵子发生。综上所述,我们处于独特的地位,可以阐明基本的生殖系
确保基因组维护、基因组防御和表观遗传基因调控的机制相互交叉
系统层面。本申请中提出的研究方向是内聚性和协同性的,具有很高的
有潜力维持研究进展,并为生殖系生物学的重大、变革性进展提供信息;
人类生殖和生殖健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Satoshi Namekawa其他文献
Satoshi Namekawa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Satoshi Namekawa', 18)}}的其他基金
Epigenetic Regulation of Gene Expression during Spermatogenesis
精子发生过程中基因表达的表观遗传调控
- 批准号:
10292862 - 财政年份:2018
- 资助金额:
$ 22.01万 - 项目类别:
Epigenetic Regulation of Gene Expression during Spermatogenesis
精子发生过程中基因表达的表观遗传调控
- 批准号:
9894901 - 财政年份:2018
- 资助金额:
$ 22.01万 - 项目类别:
Histone Lysine Crotonylation in Paternal Epigenetic Inheritance
父系表观遗传中的组蛋白赖氨酸巴豆酰化
- 批准号:
9162845 - 财政年份:2016
- 资助金额:
$ 22.01万 - 项目类别:
DNA Damage Response Pathways in Meiotic Sex Chromosome Inactivation
减数分裂性染色体失活中的 DNA 损伤反应途径
- 批准号:
8896814 - 财政年份:2011
- 资助金额:
$ 22.01万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 22.01万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 22.01万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 22.01万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 22.01万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 22.01万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 22.01万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 22.01万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 22.01万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 22.01万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 22.01万 - 项目类别:
Research Grant